Which has the lower trailing P/E, DXCM or MDLN?

DXCM has the lower trailing P/E: DXCM trades at 34.48 and MDLN at 37.42. P/E is one valuation measure and does not by itself establish which business is cheaper.

Is DXCM or MDLN more profitable?

DXCM runs the higher net margin — DXCM at 20.12% versus MDLN at 2.31%.

DexCom, Inc. (DXCM) vs Medline Inc. (MDLN)

A side-by-side comparison of DexCom, Inc. and Medline Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

DXCM

DexCom, Inc.

$32.92B

$87.24HealthcareDelayed quote: Sep 15, 2026, 2:20 PM EDT

MDLN

Medline Inc.

$27.21B

$32.18HealthcareDelayed quote: Sep 15, 2026, 2:20 PM EDT

Total return — DXCM vs MDLN

growth of $100 · dividends reinvested · last 1y

DXCM +25.1% (+25.1%/yr)MDLN -20.7% (-20.7%/yr)DXCM compounded faster over this window

DXCM MDLN

DXCM vs MDLN: by the numbers

•DXCM is the larger company ($32.92B vs $27.21B market cap).
•DXCM trades at the lower trailing earnings multiple (34.48 vs 37.42 P/E), one valuation lens rather than an overall verdict.
•DXCM converts more revenue to profit (20.12% vs 2.31% net margin).

Metrics side by side

Valuation

Metric	DXCM	MDLN
P/E ratio	34.48	37.42
Forward P/E	32.70	21.56
P/S ratio	6.63	0.91
P/B ratio	12.56	2.35
EV / EBITDA	23.67	13.62
FCF yield	4.27%	4.93%

Profitability

Metric	DXCM	MDLN
Gross margin	62.47%	25.02%
Operating margin	22.92%	6.07%
Net margin	20.12%	2.31%
ROE	38.14%	5.97%
ROIC	21.71%	4.05%

Growth (annualized)

Metric	DXCM	MDLN
Revenue CAGR (5Y)	18.03%	N/A
EPS CAGR (5Y)	10.31%	N/A
FCF CAGR (5Y)	69.49%	N/A
Total return CAGR (5Y)	-9.57%	N/A

Frequently asked

Which has the lower trailing P/E, DXCM or MDLN?: DXCM has the lower trailing P/E: DXCM trades at 34.48 and MDLN at 37.42. P/E is one valuation measure and does not by itself establish which business is cheaper.
Is DXCM or MDLN more profitable?: DXCM runs the higher net margin — DXCM at 20.12% versus MDLN at 2.31%.

Go deeper

Full DXCM analysis Full MDLN analysis Interactive comparison tool

Dig into the metrics

DexCom P/E ratio Medline P/E ratio DexCom ROE Medline ROE DexCom operating margin Medline operating margin DexCom revenue growth Medline revenue growth DexCom free cash flow Medline free cash flow

DexCom & Medline appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.